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Abstract
There has been increasing interest in recent years in the development of approaches to estimate causal
effects when the number of potential confounders is prohibitively large. This growth in interest has led to a
number of potential estimators one could use in this setting. Each of these estimators has different operating
characteristics, and it is unlikely that one estimator will outperform all others across all possible scenarios.
Coupling this with the fact that an analyst can never know which approach is best for their particular data,
we propose a synthetic estimator that averages over a set of candidate estimators. Averaging is widely used in
statistics for problems such as prediction, where there are many possible models, and averaging can improve
performance and increase robustness to using incorrect models. We show that these ideas carry over into
the estimation of causal effects in high-dimensional scenarios. We show theoretically that averaging provides
robustness against choosing a bad model, and show empirically via simulation that the averaging estimator
performs quite well, and in most cases nearly as well as the best among all possible candidate estimators.
Finally, we illustrate these ideas in an environmental wide association study and see that averaging provides
the largest benefit in the more difficult scenarios that have large numbers of confounders.
1 Introduction
Estimating the causal effect of a treatment on an outcome with observational data relies on the assumption that
the treatment assignment is unconfounded conditional on a set of pre-treatment covariates. There is a large
literature on methods to adjust for confounding in order to satisfy this assumption, such as matching (Rubin
& Thomas, 1996), propensity score weighting (Rosenbaum & Rubin, 1983), stratification, outcome regression,
and doubly robust estimators (Bang & Robins, 2005). These approaches have all been shown to provide valid
estimates of causal effects as long as the covariates necessary for the unconfoundedness assumption to hold
are measured in the data. In recent years, the number of high-dimensional data sets with large numbers of
covariates has been growing, and there has been subsequent interest in the estimation of causal effects in such
high-dimensional settings. This is both a blessing and a curse: the increasing number of measured covariates
makes it more plausible that the covariates necessary for confounding adjustment have been included, however,
estimation becomes considerably more difficult with large numbers of parameters. Due to this, there has been
a spike in interest in methods to adjust for large numbers of covariates and produce consistent estimates of
causal effects from observational data.
Much of the interest began as papers started to consider the problem of variable selection or model selection
for causal estimation in low-dimensional settings (Crainiceanu et al. , 2008; Vansteelandt et al. , 2012; Wang
et al. , 2012). Since then, a large number of manuscripts have been published that aim to estimate causal effects
when the number of covariates is large relative to the sample size. Wilson & Reich (2014) tailored the adaptive
lasso (Zou, 2006) to effect estimation instead of prediction, by creating weights that involve both outcome
model and treatment model coefficients. Other approaches have utilized penalization approaches to estimate
causal effects in high-dimensions. Shortreed & Ertefaie (2017) used the adaptive lasso within the propensity
score framework, but allowed the weights to depend on the outcome model coefficients. Ertefaie et al. (2018)
create a new penalization estimator that utilizes information from both the treatment and outcome to identify
confounders, and then estimate causal effects conditional on this set of variables. The lasso Tibshirani (1996)
was used to estimate both propensity score and prognostic score models in Antonelli et al. (2016) to obtain
doubly robust estimates via matching. Antonelli et al. (2017a) utilize a fully Bayesian approach to estimating
treatment effects in high-dimensions that attempts to reduce finite sample bias while eliminating the impact of
instrumental variables. Hahn et al. (2016) utilize horseshoe priors on a re-parameterized likelihood to reduce
shrinkage of important coefficients. A large number of approaches have focused on obtaining uniformly valid
inference of causal effects in high-dimensions (Belloni et al. , 2014; Farrell, 2015; Chernozhukov et al. , 2018).
Belloni et al. (2014) use lasso models to estimate both the treament and outcome model parameters, taking the
union of the identified covariates from the two models, and then estimating effects conditional on the chosen
model. Farrell (2015) also utilize the lasso for a treatment and outcome model, and then fit post selection
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estimators to estimate the traditional doubly robust estimator. Chernozhukov et al. (2018) estimate nuisance
parameters such as treatment or outcome model parameters via penalization, and then solve the efficient score
to estimate treatment effects. Similar ideas are used from the Bayesian perspective in Antonelli & Dominici
(2018), and it is shown that it leads to improved finite sample performance of frequentist metrics such as interval
coverage. Other approaches have shown that
√
n convergence can be achieved in high-dimensional settings.
Athey et al. (2018) combine high-dimensional outcome regression with balancing weights that eliminate any
residual confounding after the outcome regression. Propensity score estimation is improved for both high-
dimensions and model misspecification using calibration weights in Tan (2017, 2018). Propensity scores are
again used in high-dimensional scenarios, but are instead estimated by their ability to balance important
covariates in Ning et al. (2018). Lastly, targeted maximum likelihood (TMLE, Van Der Laan & Rubin (2006))
can be used in conjuction with high-dimensional models to produce valid estimates of treatment effects.
This recent interest has led to a diverse and large set of potential estimators to use if one is faced with
observational data that is high-dimensional. Choosing among this large set of estimators is a subjective choice,
and it is not clear if, or when, any estimators are preferable to others. Given the complexity faced with high-
dimensional data, it is highly unlikely that any one estimator will perform well universally. In this manuscript,
we propose a synthetic estimator that is a convex combination of candidate estimators. The idea of combining
models, estimators, or tests has a rich history in the statistical literature. For example, model uncertainty
can be accounted for through model averaging, which exists in both the Bayesian and frequentist framework
(Draper (1995); Hoeting et al. (1999); Hjort & Claeskens (2003); Hansen (2007)). Others have proposed
combinations of estimators (Mittelhammer & Judge (2005); Antonelli et al. (2017b)), including in the field of
small area estimation (Ghosh et al. (1994)). Omnibus tests for the global null hypothesis simultaneously test
multiple hypotheses (e.g. ANOVA), and several methods for combining individual p-values from genome-wide
association studies have been proposed (Chen & Yang (2017)). These are just a few examples of combining
models, estimators, or tests, but they all share a common goal: combining statistics for improved performance.
In this manuscript, we leverage a large set of potential estimators to our advantage by introducing a
simple, intuitive estimator that averages over all of the candidate estimators. We will show both theoretically
and empirically that this leads to robust performance for estimating treatment effects in high-dimensions. In
particular, averaging over all existing estimators can lead to an estimate with reduced bias and mean squared
error (MSE), as well as increased coverage probabilities.
2 Methodology
Throughout, we will assume that we have n i.i.d samples of (Yi, Ti,Xi). Yi and Ti are the outcome and treat-
ment of interest, respectively, while Xi is a p−dimensional vector of pre-treatment covariates. We will assume
that Ti is a binary treatment as many of the existing estimators are only applicable to binary treatments.
We will not discuss the rates at which p grows, but we will be working in the high-dimensional regime that
p > n and grows with n. For simplicity, we will restrict attention to the average treatment effect defined as
ATE = E(Y (1)−Y (0)), where Yi(t) is the potential outcome we would have observed for subject i if they had
been exposed to treatment Ti = t. We will be working under the assumptions of no unmeasured confounding
and positivity, defined below:
Unconfoundedness: Y (t) ⊥ T |X for t=0,1
Positivity: There exist δ ∈ (0, 1) such that 0 < δ < P (T = 1|X) < 1− δ < 1 with probability 1,
where P (T = 1|X) denotes the propensity score (Rosenbaum & Rubin, 1983). We will also assume the
stable unit treatment value assumption (SUTVA), which states that the treatment is well-defined and that
the outcomes for one subject are not affected by the treatment status of other subjects. Further, in high-
dimensional settings, many of the estimators we consider will rely on some form of sparsity, essentially stating
that unconfoundedness holds conditional of a subset of the covariates. The exact form of the sparsity condition
varies by estimator and will not be discussed in detail in this manuscript.
2.1 Averaged estimator
We now detail how to construct the averaged estimator, conditional on the fact that there exist M estimators
from which to choose. We will denote each estimator by θ̂m for m = 1, . . . ,M . Each estimator will also have a
corresponding variance estimate, which we will denote by σ̂2m for m = 1, . . . ,M . The averaged estimator takes
the form
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θ̂A =
M∑
m=1
wmθ̂m,
where w is a weight vector that must be chosen. In an ideal world, we would estimate the weight vector to try
and obtain the optimal choice that minimizes a pre-specified loss function. One example would be to find the
weight vector that minimizes the mean squared error of θ̂A, which would amount to solving
argmin
w
wTV w + (wTB)2,
where B and V are the bias vector and covariance matrix for the M estimators. Unfortunately, both of these
quantities are quite difficult to estimate. In the context of noncompliance in clinical trials, Antonelli et al.
(2017b) are able to estimate these two quantities and estimate the weight vector w. The bias is estimated by
identifying an unbiased estimator among the candidate estimators, and the covariance is estimated using the
bootstrap. These ideas do not carry over into the high-dimensional estimators considered here. The bootstrap
does not apply to most of the high-dimensional estimators based on variable selection or regularization, and
estimating the bias of each estimator is infeasible. Further, most of the papers mentioned in the introduction
went to great detail simply to estimate the variance of their estimators in high-dimensions, so finding the
covariance between each respective estimator is not possible at this point. With this in mind, we will proceed
forward with a fixed weight vector w = (1/M, 1/M, . . . , 1/M), such that each estimator gets equal weight. This
provides a number of advantages over simply choosing a single estimator, which are detailed in the subsequent
sections. The averaging will provide a form of robustness in terms of bias and MSE by ensuring that the
averaged estimator does better in terms of these metrics than the worst of the M estimators. Our empirical
studies in Section 3 show that we not only provide protection against choosing the worst estimator, but the
averaged estimator typically does close to, if not better, than the best of the M estimators. This is due to large
decreases in the variance of the averaged estimator relative to any one estimator, particularly if the individual
estimators are not strongly correlated. We would like to note that unequal weights can easily be applied here
as long as they are chosen a priori and not chosen simply to provide a desired result.
2.2 Variance estimation
One reason that utlizing the averaged estimator can be so powerful is that it can lead to large gains in efficiency.
If the covariance matrix V of the M estimators is known, the variance of the averaged estimator can be written
as
var(θ̂A) =
1
M2
M∑
i=1
M∑
j=1
Vij .
We can explore this quantity in various situations to see how the variance can be greatly improved with the
averaged estimator. In one extreme case where all the estimators are perfectly correlated, then the variance
of the averaged estimator is equal to the average of the pairwise products of the standard deviations for
each estimator. If each estimator has the same variance, this would lead to the averaged estimator having
the exact same variance as the other estimators. In a different extreme case where all of the estimators are
uncorrelated, the variance of the averaged estimator would be 1
M2
∑M
i=1 Vii. This means that the variance
of the averaged estimator would be an order of magnitude (1/M) smaller than the average of the individual
estimator variances. Even bigger gains can be seen if the estimators are negatively correlated, but this is very
unlikely to happen in practice so it will not be discussed any further. In our experience, these estimators
will be positively, but not perfectly, correlated with each other, meaning that the truth lies between the two
extremes discussed. Nonetheless, the variance of the averaged estimator can either be a big improvement over
the individual estimators, or in the worst case scenario, it is no worse.
The difficult aspect of using the high-dimensional averaged estimator proposed is to estimate its correspond-
ing variance. We could plug in estimates into the expression above, however, as discussed earlier it is very
difficult to produce an estimate of V in high-dimensions. We can, however, estimate the individual estimator
variances σ̂2m. Since the correlation is bounded between -1 and 1, we can bound the variance of the averaged
estimator via
var(θ̂A) =
1
M2
M∑
i=1
M∑
j=1
Vij =
1
M2
M∑
i=1
M∑
j=1
cor(θ̂i, θ̂j)
√
Vii
√
Vjj ≤ 1
M2
M∑
i=1
M∑
j=1
√
Vii
√
Vjj .
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Therefore, we can propose a conservative estimate of the variance as
σ̂2A =
1
M2
M∑
i=1
M∑
j=1
σ̂iσ̂j .
The amount that this estimator is conservative or not depends on the correlation between the individual
estimators. If they are highly, positively correlated, then this will not be very conservative. If the estimators
are close to independent, then this estimator will be a very conservative estimate of the variance. We argue that
being conservative in this setting is good for two reasons. First, the estimates of standard errors σ̂m frequently
rely on asymptotic approximations, which might not hold, and therefore these could be underestimates of the
true individual variances. Second, there is frequently bias in estimating treatment effects in high-dimensions
due to penalization or variable selection, and therefore conservative estimates of the variance might lead to
better interval coverages that help to account for some additional bias. We will see empirically that this
conservative variance does quite well in Section 3.
2.3 Robustness to choosing the worst model
The extent to which the averaged estimator performs relative to the candidate estimators is highly data depen-
dent. However, we show that the averaged estimator protects against choosing a potentially very bad estimator
among the class of estimators. Intuitively, this is because the averaged estimator only assigns a weight of 1/M
to any one estimator, including the worst estimator with respect to a given metric, and therefore it will per-
form as good or better than this worst case estimator. The following result shows this for both bias and mean
squared error:
Result 1: If each estimator is assigned equal weight, and we let θ̂∗ and θ̂∗∗ be the worst estimators in terms of
bias and MSE, respectively, then
|E(θ̂A − θ)| ≤ |E(θ̂∗ − θ)| and E((θ̂A − θ)2) ≤ E((θ̂∗∗ − θ)2)
A proof of this result can be found in the Appendix. While this result only guarantees that the averaged
estimator does better than the worst model, in practice these are typically very conservative bounds, as the
averaged estimator not only performs better than the worst estimators, but frequently performs similarly well
to the best individual estimators.
3 Simulation study
We will empirically investigate the ability of the averaged estimator to estimate treatment effects in high-
dimensional settings. We focus on 10 potential estimators that are either available in an R package, or
straightforward to implement ourselves. The estimators to enter into the averaged estimator are listed below:
1. The double post selection approach (Double PS, Belloni et al. (2014))
2. The approximate residual debiasing approach (Debiasing, Athey et al. (2018))
3. The doubly robust lasso approach (DR-Lasso, Farrell (2015))
4. Doubly robust matching (DRME, Antonelli et al. (2016))
5. High-dimensional confounding with spike-and-slab priors (HDC, Antonelli et al. (2017a))
6. Bayesian doubly robust estimator (DR-Bayes, Antonelli & Dominici (2018))
7. Targeted maximum likelihood with lasso models (TMLE, Van Der Laan & Rubin (2006))
8. Targeted maximum likelihood with an initial screening step followed by unpenalized linear models
(TMLE-screen)
9. Double machine learning with lasso models (DML, Chernozhukov et al. (2018))
10. Double machine learning with post selection estimators (DML-PS)
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We will not go into the details of the respective approaches or how they are fit, as our aim here is to show the
performance of the averaged estimator when there are a large number of estimators to average over, each with
varying operating characteristics that are unknown to the user beforehand. For this reason, we will focus on
results for the averaged estimator, as well as the best and worst estimator with respect to any given metric.
For mean squared error, the best estimator is the one with the smallest MSE, and the worst is the one with
the largest MSE. For ease of discussion, the MSE for each simulation scenario is normalized so that the best
estimator has MSE equal to 1. For interval coverage, the worst estimator is the one with the lowest coverage,
and then the best estimator is the one with the coverage closest to 0.95 without being 1. We don’t want an
estimator with a coverage probability of 1 as it could be overly conservative. This was not an issue in any of
the five scenarios we considered. For the first three simulation scenarios, we generated data under the following
models for the treatment and the outcome processes:
Yi = Ti +Xiβ + i
P (Ti = 1) = Xiγ
Xi ∼ MVN(0p,ΣX)
i ∼ N (0, 1),
where ΣX is an exchangeable correlation matrix with correlation 0.3. In all three of these scenarios, n = 150
and p = 300. In scenario 1, β = (0.75, 1, 0.6,−0.8,−0.7,0p−5), and γ = (0.15, 0.2, 0, 0,−0.4,0p−5). In scenario
2, both β and γ are 0p and there is no confounding. In scenario 3, β = (0.9, 0.9, 0.2, 0.2, 0, 0, 0.9, 0.9,0p−8), and
γ = (0.4, 0.9,−0.5,−0.7,−0.3, 0.6,0p−6). The final two simulation scenarios are based on a simulation from
Athey et al. (2018) that has a dense treatment model. For the fourth scenario, define 20 clusters, {c1, . . . , c20}
where ck ∼ N (0, Ip). We draw Ci uniformly at random from one of the 20. Then, we draw the covariates
from a multivariate normal distribution centered at Ci with the identity matrix as the covariance. We set
Ti = 1 with probability 0.1 for the first 10 clusters, and Ti = 1 with probability 0.9 for the remaining clusters.
Finally, we generate data from the outcome model defined as Yi = 10Ti +Xβ + i, where β ∝ (1, 1√2 , . . . ,
1√
p)
and is normalized such that ||β||22 = 18. The fifth scenario is the same as the fourth, except that Ti = 1 with
probability 0.25 and 0.75 for the first 10 and remaining clusters, respectively. Further, we set β ∝ (1, 12 , . . . , 1p).
3.1 Results
Figures 1 and 2 show the results averaged over 1000 simulations for both MSE and interval coverage. We
see that the averaged estimator does quite favorably in terms of both MSE and interval coverage. In terms
of MSE, the worst estimator does significantly worse than the averaged estimator in all scenarios, while the
averaged estimator is able to achieve an MSE that is close to the best of the individual estimators. While it
is hard to see in the figure because the differences are small, the averaged estimator does slightly better than
the best estimator in Scenario 3. As far as interval coverages, the averaged estimator achieves coverages near
the nominal 0.95 level in nearly all of the simulation scenarios looked at, and significantly outperforms the
worst estimator. There is one scenario in which the coverage of the averaged estimator is overly conservative,
which was Scenario 4 and the coverage probability was 1. The reason for this was not due to us using an upper
bound for the variance, it was because one of the estimators performed poorly with extremely high standard
errors that propagated into the averaged estimator’s standard error. Nonetheless, we would argue that airing
on the side of being conservative is preferred to anti-conservative intervals. In practice, we would exclude any
estimator with an extreme estimated standard error from the average, which hopefully would avoid this issue.
Overall, the results confirm the theoretical results that the averaged estimator does better than the worst
individual estimator, though more importantly, they show that in fact, the averaged estimator tends to perform
more closely to the best individual estimator. Figure 3 shows the absolute bias and variance for each individual
estimator across all the simulation scenarios considered. The circles represent the individual estimators while
the triangles represent the averaged estimator for each scenario. The averaged estimator tends to lie in the lower
left of the plot compared with the individual estimators for a given simulation, indicating that the averaged
estimator has both a small bias and small variance in each scenario.
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Figure 1: Mean squared error for the estimator with the lowest MSE, highest MSE,
and the averaged estimator.
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Figure 2: Interval coverage for the estimator with the best interval coverage, worst
interval coverage, and for the averaged estimator.
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Figure 3: Bias and variance for each of the estimators, over all scenarios looked at.
The averaged estimators are denoted by large triangles, while the other estimators are
denoted by small circles.
4 Application to NHANES data
Environmental wide association studies (EWAS) measure a variety of chemicals and toxins that humans are
exposed to in an effort to understand how they affect the biological processes in the human body (Wild,
2005; Patel & Ioannidis, 2014). The National Health and Nutrition Examination Survey (NHANES), is a
cross-sectional data source made publicly available by the Centers for Disease Control and Prevention (CDC),
and we will aim to estimate the effects of a number of environmental exposures on three different outcomes:
HDL cholesterol levels, LDL cholesterol levels, and triglyceride levels in the NHANES study. We will use the
data found in Wilson et al. (2018), which contains a large number of potential confounders. Participants
both fill out questionnaires regarding their health status, as well as receive clinical and laboratory tests that
contain information on environmental factors such as pollutants, allergens, bacterial/viral organisms, chemical
toxicants, and nutrients. In previous work (Patel et al. , 2012), the environmental agents were separated into
different groups containing similar agents that might affect similar biological pathways. We will look at the
effects of 22 different environmental agent groups on the three outcomes, leading to 66 different analyses. Each
exposure we look at is defined as the average exposure level across all agents within the same grouping. As
most of the approaches considered only look at binary treatments, we dichotomize the continuous exposure by
classifying each exposure as being above or below the median exposure level. Each of the environmental agents
looked at is measured in a different subset of the NHANES data, leading to different populations, sample
sizes, and covariate dimensions for each of the 22 different exposures. Some of the data sets have very small
p/n ratios that do not require high-dimensional techniques, while others have p/n ratios between 0.3-0.4 and
require some form of dimension reduction. In the following sections we will see how the averaged estimator
performs in comparison with the individual estimators, and how this varies as a function of the p/n ratio.
4.1 Agreement of statistical decisions
Here we evaluate whether the averaged estimator would lead to any different decisions in terms of hypothesis
testing. In particular, if we were interested in testing whether the ATE was 0 or not, do the different estimators
lead to different conclusions. Figure 4 shows the results of this statistical test for any data set in which there
was disagreement among the estimators. Each row corresponds to a particular estimator, while each column
corresponds to a particular data set. We see that the averaged estimator generally sides with the majority of
the individual estimators in terms of testing the null hypothesis, though this is not always the case. In the
sixth column, only 3 of the 10 estimators show a significant treatment effect, and the averaged estimator also
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leads to a rejection of the null hypothesis of no treatment effect. It is important to emphasize that Figure 4 is
limited to cases where different estimators lead to different conclusions, which represents only 30% of analyses
performed.
Double PS
DR−Lasso
Debiasing
DML
DML−PS
TMLE
TMLE−screen
DR−Match
DR−Bayes
HDC
Averaged
value
Not Significant
Significant
Testing null treatment effect
Figure 4: Plot of whether or not each estimator rejected a particular null hypothesis.
The results only show data sets in which there was some disagreement among the 11
estimators in terms of the final hypothesis test.
4.2 When does averaging matter?
Here we evaluate the potential impact that averaging can have on estimation within the NHANES data set,
and will try to identify where it is the most useful. Assuming that each estimator has only a small amount of
bias, the main advantage of averaging is the efficiency gains one can achieve. When the individual estimators
are highly correlated, there is very little to be gained (though also very little to be lost) by using averaging.
On the other hand, as estimators have smaller and smaller correlations with each other, the averaged estimator
gains more and more efficiency. The left panel of Figure 5 shows the correlation matrix of the 10 estimators
across the data sets examined. We see that the correlation is generally very high, with the majority of the
values on the off-diagonal above 0.9. The right panel, however, depicts a somewhat different story when we
restrict to the data sets with p/n ratios above 0.25. In these settings we see much smaller correlation between
the estimators, with some of the correlations down in the 0.4 range, and many more in the 0.6 to 0.8 range.
These two panels show that when p/n is small, there is very little to be gained by averaging. In the more
difficult settings with larger numbers of covariates, averaging has the potential to reduce the variance of the
treatment effect estimate substantially. These more difficult scenarios are exactly the types of scenarios that all
of the aforementioned high-dimensional approaches were developed for, and we can see that in these scenarios,
averaging over all the potential estimators can lead to improved estimation.
5 Discussion
We have presented a simple approach to estimating average treatment effects in high-dimensions that leverages
all of the estimators that have been developed in recent years. As more and more approaches are developed,
it becomes more difficult for an analyst to choose an approach for their particular study. Further, there is
likely no best approach in all scenarios, and the extent to which each estimator performs is highly dependent
on the unknown data generating process. We have argued in this manuscript that averaging over all of the
estimators provides an ideal choice when presented with so many estimators. Not only does the averaged esti-
mator guarantee improved performance over the worst estimator in terms of bias and MSE, but our empirical
results indicate that it can perform much more closely to the best of the individual estimators without knowing
beforehand which estimators are best. At times, it can even outperform the best of the individual estimators.
Further, we saw that our conservative estimate of the variance of the averaged estimator leads to good per-
formance in terms of confidence interval coverages. In high-dimensional settings there is typically both bias
of statistical estimators, and underestimation of the uncertainty associated with estimators, and therefore our
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Figure 5: Correlation matrix across the 10 estimators over the analyses in the NHANES
data. The right panel only shows this correlation for those data sets with a p/n ratio
that is above 0.25
conservative variance estimate seems to help mitigate these issues to obtain better finite sample performance.
A potential criticism of the averaged estimator is that each individual estimator relies on its own set of
assumptions, and therefore the averaged estimator assumes all of these assumptions in order to achieve unbiased
inference. While this is generally true, we argue that in some ways this shows the strength of the averaged
estimator. All of these assumptions are untestable, and we don’t know which estimator’s assumptions are being
violated. By averaging over all estimators, we mitigate the impact that gross misspecification of one of these
assumptions could have if we simply chose the one, bad estimator. Ideally, we would estimate the weights w
to optimize the averaged estimator, and reduce the impact that one bad estimator could have on the averaged
estimator. Unfortunately, this is a very difficult problem because it requires at least the covariance matrix of
the individual estimators, if not also the bias for each estimator. In high-dimensions it is not possible to obtain
these quantities for a general set of estimators, and even if we could, the estimation of the weights would likely
increase the variance of our averaged estimator enough to remove any benefits from adaptive weight estimation.
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A Proof of result 1
First we will show the result for bias:
∣∣∣∣E( 1M
M∑
m=1
θ̂m
)
− θ
∣∣∣∣ = ∣∣∣∣ 1M
M∑
m=1
(
E(θ̂m)− θ
)∣∣∣∣
≤ 1
M
M∑
m=1
∣∣E(θ̂m)− θ∣∣
≤ 1
M
M∑
m=1
∣∣E(θ̂∗)− θ∣∣
=
∣∣E(θ̂∗)− θ∣∣
Now for the MSE:
E
[(
1
M
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m=1
θ̂m − θ
)2]
= E
[
1
M2
( M∑
m=1
(θ̂m − θ)
)2]
=
1
M2
E
[ M∑
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(θ̂m − θ)2 +
∑
i 6=j
(θ̂i − θ)(θ̂j − θ)
]
≤ 1
M2
E
[ M∑
m=1
(θ̂m − θ)2 +
∑
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|θ̂i − θ||θ̂j − θ|
]
≤ 1
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[
M ∗ E((θ̂∗∗ − θ)2)+∑
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√
E
(
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)
E
(
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[
M ∗ E((θ̂∗∗ − θ)2)+∑
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E
(
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